446 related articles for article (PubMed ID: 22971158)
21. Acute intoxication by synthetic cannabinoids--four case reports.
Hermanns-Clausen M; Kneisel S; Hutter M; Szabo B; Auwärter V
Drug Test Anal; 2013; 5(9-10):790-4. PubMed ID: 23696237
[No Abstract] [Full Text] [Related]
22. The "new" marijuana.
Wells DL; Ott CA
Ann Pharmacother; 2011 Mar; 45(3):414-7. PubMed ID: 21325097
[TBL] [Abstract][Full Text] [Related]
23. An accidental fatal intoxication with methoxetamine.
Wikström M; Thelander G; Dahlgren M; Kronstrand R
J Anal Toxicol; 2013; 37(1):43-6. PubMed ID: 23111916
[TBL] [Abstract][Full Text] [Related]
24. Delayed seizure-like activity following analytically confirmed use of previously unreported synthetic cannabinoid analogues.
Schep LJ; Slaughter RJ; Hudson S; Place R; Watts M
Hum Exp Toxicol; 2015 May; 34(5):557-60. PubMed ID: 25233895
[TBL] [Abstract][Full Text] [Related]
25. Determination of 22 synthetic cannabinoids in human hair by liquid chromatography-tandem mass spectrometry.
Hutter M; Kneisel S; Auwärter V; Neukamm MA
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Aug; 903():95-101. PubMed ID: 22835826
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of synthetic cannabinoids in U.S. athletes: initial findings.
Heltsley R; Shelby MK; Crouch DJ; Black DL; Robert TA; Marshall L; Bender CL; DePriest AZ; Colello MA
J Anal Toxicol; 2012 Oct; 36(8):588-93. PubMed ID: 22872465
[TBL] [Abstract][Full Text] [Related]
27. Simultaneous detection of multiple designer drugs in serum, urine, and CSF in a patient with prolonged psychosis.
Thornton SL; Lo J; Clark RF; Wu AH; Gerona RR
Clin Toxicol (Phila); 2012 Dec; 50(10):1165-8. PubMed ID: 23163617
[TBL] [Abstract][Full Text] [Related]
28. A case of cannabinoid hyperemesis syndrome caused by synthetic cannabinoids.
Hopkins CY; Gilchrist BL
J Emerg Med; 2013 Oct; 45(4):544-6. PubMed ID: 23890687
[TBL] [Abstract][Full Text] [Related]
29. Simultaneous analysis of synthetic cannabinoids in the materials seized during drug trafficking using GC-MS.
Choi H; Heo S; Choe S; Yang W; Park Y; Kim E; Chung H; Lee J
Anal Bioanal Chem; 2013 May; 405(12):3937-44. PubMed ID: 23208283
[TBL] [Abstract][Full Text] [Related]
30. [Spice in France: mixed herbs containing synthetic cannabinoids].
Schlatter J; Chiadmi F; Chariot P
Ann Biol Clin (Paris); 2012; 70(4):413-22. PubMed ID: 22796613
[TBL] [Abstract][Full Text] [Related]
31. Quantification of selected synthetic cannabinoids and Δ9-tetrahydrocannabinol in oral fluid by liquid chromatography-tandem mass spectrometry.
de Castro A; Piñeiro B; Lendoiro E; Cruz A; López-Rivadulla M
J Chromatogr A; 2013 Jun; 1295():99-106. PubMed ID: 23680386
[TBL] [Abstract][Full Text] [Related]
32. Analysis of synthetic cannabinoids in "spice-like" herbal highs: snapshot of the German market in summer 2011.
Simolka K; Lindigkeit R; Schiebel HM; Papke U; Ernst L; Beuerle T
Anal Bioanal Chem; 2012 Jul; 404(1):157-71. PubMed ID: 22710567
[TBL] [Abstract][Full Text] [Related]
33. Analytical confirmation of synthetic cannabinoids in a cohort of 179 presentations with acute recreational drug toxicity to an Emergency Department in London, UK in the first half of 2015.
Abouchedid R; Hudson S; Thurtle N; Yamamoto T; Ho JH; Bailey G; Wood M; Sadones N; Stove CP; Dines A; Archer JRH; Wood DM; Dargan PI
Clin Toxicol (Phila); 2017 Jun; 55(5):338-345. PubMed ID: 28421836
[TBL] [Abstract][Full Text] [Related]
34. Synthetic cannabinoids in oral fluid.
Coulter C; Garnier M; Moore C
J Anal Toxicol; 2011 Sep; 35(7):424-30. PubMed ID: 21871150
[TBL] [Abstract][Full Text] [Related]
35. Acute kidney injury associated with smoking synthetic cannabinoid.
Buser GL; Gerona RR; Horowitz BZ; Vian KP; Troxell ML; Hendrickson RG; Houghton DC; Rozansky D; Su SW; Leman RF
Clin Toxicol (Phila); 2014 Aug; 52(7):664-73. PubMed ID: 25089722
[TBL] [Abstract][Full Text] [Related]
36. Identification of synthetic cannabinoids in herbal incense blends in the United States.
Logan BK; Reinhold LE; Xu A; Diamond FX
J Forensic Sci; 2012 Sep; 57(5):1168-80. PubMed ID: 22834927
[TBL] [Abstract][Full Text] [Related]
37. Urinary prevalence, metabolite detection rates, temporal patterns and evaluation of suitable LC-MS/MS targets to document synthetic cannabinoid intake in US military urine specimens.
Wohlfarth A; Scheidweiler KB; Castaneto M; Gandhi AS; Desrosiers NA; Klette KL; Martin TM; Huestis MA
Clin Chem Lab Med; 2015 Feb; 53(3):423-34. PubMed ID: 25263309
[TBL] [Abstract][Full Text] [Related]
38. Toxicological profiles of selected synthetic cannabinoids showing high binding affinities to the cannabinoid receptor subtype CB₁.
Koller VJ; Zlabinger GJ; Auwärter V; Fuchs S; Knasmueller S
Arch Toxicol; 2013 Jul; 87(7):1287-97. PubMed ID: 23494106
[TBL] [Abstract][Full Text] [Related]
39. Quadrupole-time-of-flight mass spectrometry screening for synthetic cannabinoids in herbal blends.
Ibáñez M; Bijlsma L; van Nuijs AL; Sancho JV; Haro G; Covaci A; Hernández F
J Mass Spectrom; 2013 Jun; 48(6):685-94. PubMed ID: 23722959
[TBL] [Abstract][Full Text] [Related]
40. Detection Times of Carboxylic Acid Metabolites of the Synthetic Cannabinoids JWH-018 and JWH-073 in Human Urine.
Hegstad S; Westin AA; Spigset O
J Anal Toxicol; 2015 May; 39(4):280-6. PubMed ID: 25737323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
